PCD logo

Use of Cancer Screening Tests, United States, 2023

ORIGINAL RESEARCH ¡ª Volume 22 ¡ª August 14, 2025

Print
Related Pages
Age-standardized (to the 2000 US standard population) estimates of being up to date with breast, cervical, and colorectal screening test use based on US Preventive Services Task Force recommendations, by year. In 2023, percentages up-to-date increased for breast screening test use and decreased for cervical and colorectal screening test use. Percentages are weighted. Colorectal cancer screening estimates are based on US Preventive Services Task Force-recommended screening ages for each year (ages 50–75 years for 2021 and ages 45–75 years for 2023). The colorectal screening estimate for 2019 is not shown because of differences in colorectal screening test use data available in that year. Data source: National Health Interview Survey.
Screening test % (95% CI)
2019 2021 2023
Breast cancer 76.2 (74.9–77.5) 75.6 (74.4–76.8) 79.8 (78.5–81.1)
Cervical cancer 80.0 (78.9–81.1) 79.1 (77.9–80.3) 75.8 (74.6–77.0)
Colorectal cancer Not applicable 70.3 (69.3–71.4) 63.5 (62.5–64.5)

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.